← View All Sponsored Content

Advances in Autoimmune Pulmonary Alveolar Proteinosis

Tuesday, May 20, 1:00 PM–2:00 PM PDT
Innovation Theater 3 (inside the exhibit hall)

Bruce Trapnell, MD, and Cormac McCarthy, MD, PhD, will provide an update on autoimmune pulmonary alveolar proteinosis, including the pathophysiology of this rare lung disease, its signs and symptoms, burden of illness, and diagnosis and management of the disease.

Lunch will be provided by the American Thoracic Society. We hope to see you there!

A simple blood test can help confirm or rule out aPAP at no cost to you or your patients. This test, which can help obtain a definitive diagnosis sooner, is now available in dried blood spotform.1,2* Learn more and request the test at apapclearpath.com/hcp.

Learn more at Booth #243

*Dried blood spot testing is not yet offered in New York State.

References: 1. McCarthy C, Kokosi M, Bonella F. Shaping the future of an ultra-rare disease: unmet needs in the diagnosis and treatment of pulmonary alveolar proteinosis. Curr Opin Pulm Med. 2019;25(5):450-458. doi:10.1097/MCP.0000000000000601 2. Ataya A, Knight V, Carey BC, Lee E, Tarling EJ, Wang T. The role of GM-CSF autoantibodies in infection and autoimmune pulmonary alveolar proteinosis: a concise review. Front Immunol.
2021;12:752856. doi:10.3389/fimmu.2021.752856